
- Volume 0 0
Mallinckrodt Plans New Research Facility
Mallinckrodt's expansion and relocationof its pharmaceutical researchand development laboratory operationsare under way. The 65,000-sq-ftfacility, located on Marshall Road inWebster Groves, St. Louis, Mo, is slatedfor completion in the spring of 2005.The renovation will allow for a significantincrease in Mallinckrodt's pharmaceuticalresearch capabilities in St.Louis. It also represents the health carecompany's commitment to ongoingdevelopment of innovative genericdrug products for human use.
A large segment of the research scientistscurrently working at Mallinckrodt'sSt. Louis production plant willrelocate to the new facility upon itscompletion. Furthermore, the companyanticipates adding 20 to 25 researchersover the next year. When upand running, the facility will houseabout 100 individuals. The existing St.Louis research facilities will be redesignedto meet the expanding needsof the company's chemical business.
Articles in this issue
over 21 years ago
Treatment of Patients with Atrial Fibrillationover 21 years ago
Understanding and Managing Polypharmacy in the Elderlyover 21 years ago
Counterfeit Drugs: A Real Cause for Alarmover 21 years ago
New Treatments on the Way for Diabetes-Part 1over 21 years ago
Effective Counseling for Patients with Hypertensionover 21 years ago
Preventing and Managing Thrombosis with Anticoagulantsover 21 years ago
RxPRODUCT NEWS: PROFILE: Cardizem LA (diltiazem hydrochloride)over 21 years ago
Staying Well with Herbs and Vitaminsover 21 years ago
Health Professional Imposters-Part 1





































































































































